Summary Of Significant Accounting Policies (Details) - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Accounting Policies [Line Items]
Restricted cash	$ 0	$ 0
Deferred revenue, amortization period	1 year
Research and development receivables	$ 0	$ 0
Options and stock appreciation rights outstanding	706,494	487,146
Weighted average exercise price	$ 9.34	$ 17.21
Common stock issuable upon exercise of outstanding warrants	2,120,365	2,197,883
Exercise price of warrants	$ 4.82
Standard product warranty, coverage term	1 year
Revenues	$ 37,674,524	$ 35,011,276
Deferred financing cost assets	$ 374,978	492,385
Minimum [Member]
Accounting Policies [Line Items]
Property and equipment, estimated useful lives	3 years
Intangible assets, estimated useful lives	10 years
Share-based compensation, requisite service period	1 year
Maximum [Member]
Accounting Policies [Line Items]
Property and equipment, estimated useful lives	10 years
Intangible assets, estimated useful lives	15 years
Share-based compensation, requisite service period	4 years
Net Revenue [Member] | Customer Concentration Risk [Member] | Maximum [Member]
Accounting Policies [Line Items]
Revenues percentage	10.00%
Long-Term Debt [Member]
Accounting Policies [Line Items]
Deferred financing cost assets	$ 349,018	465,251
Line-Of-Credit Arrangements [Member]
Accounting Policies [Line Items]
Deferred financing cost assets	$ 25,960	27,134
Restricted Stock [Member]
Accounting Policies [Line Items]
Unvested restricted shares	0
Biosense Webster Inc [Member] | Net Revenue [Member]
Accounting Policies [Line Items]
Revenues	$ 3,514,897	$ 4,651,490
Revenues percentage	9.00%	13.00%